Actively Recruiting

Age: 18Years +
All Genders
NCT07333027

Lonely in Depression

Led by Friedrich-Alexander-Universität Erlangen-Nürnberg · Updated on 2026-02-24

200

Participants Needed

2

Research Sites

81 weeks

Total Duration

On this page

Sponsors

F

Friedrich-Alexander-Universität Erlangen-Nürnberg

Lead Sponsor

B

Bezirkskliniken Mittelfranken, Clinic for Psychiatry, Addiction, Psychotherapie and Psychosomatic Medicine, Am Europakanal, Germany

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this prospective study is to better understand the link between loneliness and depression in the inpatient psychiatric treatment of depression. It aims to answer: Do lonely and not lonely persons benefit the same way from inpatient depression treatment? Is loneliness a clinical relevant factor in inpatient treatment of depression? What are the underlying biopsychosocial mechanisms? Participants will be asked to do some * self-report questionnaires * clinical interview * biosampling (blood, saliva, stool) at three main measurement timepoints (1. begin of inpatient treatment, 2. day of discharge, 3. three months after discharge).

CONDITIONS

Official Title

Lonely in Depression

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • primary diagnosis of depression according to ICD-10 (F32 or F33), as diagnosed by a physician or clinical psychologist in conjunction with the M.I.N.I. Mini-International Neuropsychiatric Interview diagnostic tools
  • inpatient elective or emergency admission to one of the two psychiatric clinics; - age over 18 years
  • sufficient understanding of spoken and written German
  • informed voluntary consent
Not Eligible

You will not qualify if you...

  • a current lack of capacity to provide consent (e.g., pronounced psychotic symptoms, stuporous depressive syndrome, and thought constriction to suicidality)
  • previous participation in the study
  • pregnancy or breastfeeding
  • inpatient stay of less than 7 days, even if the patients initially met the inclusion criteria.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Friedrich-Alexander-Universität Erlangen-Nürnberg

Erlangen, Bavaria, Germany, 91054

Actively Recruiting

2

Bezirkskliniken Mittelfranken, Clinic for Psychiatry, Addiction, Psychotherapie and Psychosomatic Medicine

Erlangen, Bavaria, Germany, 91056

Not Yet Recruiting

Loading map...

Research Team

F

Franziska Sonnauer, Dr. med., M.Sc.

CONTACT

F

Franca Fries, Dr. med.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here